Comparison of DPP-4 Inhibitors versus Dapagliflozin in combination with insulin using continuous glucose monitoring in patients with type 2 diabetes mellitus -prospective randomized controlled trial-
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2017
Price : $35 *
At a glance
- Drugs Dapagliflozin (Primary) ; Sitagliptin; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Sep 2017 Status changed from active, no longer recruiting to completed.
- 06 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Sep 2014 New trial record